Tharimmune, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol: THAR on Nasdaq
Industry: Pharmaceutical Preparations
Location: 1200 Route 22 East, Bridgewater, New Jersey

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+39K	100%	$0.63	+$24.6K
Sells	0
Net	+1	+39K	100%		+$24.6K

Tharimmune, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Highpoint Pharmaceuticals LLC	10%+ Owner	$489K			Jan 11, 2022
Kufe LLC	10%+ Owner	$408K			Jan 11, 2022
Surender Kharbanda	10%+ Owner	$363K			Jan 11, 2022
Varinder Kaur	10%+ Owner	$328K			Jan 11, 2022
Sandeep Laumas	10%+ Owner	$320K			Jan 11, 2022
Randy Milby	CEO, Director	$78.7K	+$24.6K	+45.4%	Aug 9, 2024
Thomas Hess	Chief Financial Officer				Jan 11, 2022
Sireesh Appajosyula	Chief Operating Officer, Director				Aug 9, 2024
Kelly Anderson	Director				Aug 9, 2024
Lynne Bui	Director				Aug 9, 2024
Leonard L. Mazur	Director				Aug 9, 2024

Recent Insider Transactions by Companies or Individuals for Tharimmune, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.